| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
46,500,000 |
| Market
Cap: |
42.65(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.4 - $5.18 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Enochian BioSciences is a pre-clinical stage biotechnology company. Co.'s product candidates include: ENOB-HV-01 for autologous Human Immunodeficiency Virus (HIV) curative treatment; ENOB-HV-11 for preventive HIV vaccine; ENOB-HV-12 for therapeutic HIV vaccine; ENOB-HV-21 for HIV natural killer and gamma delta T-cell treatment or cure; ENOB-HV-31 for in vivo gene therapy; ENOB-HB-01 for hijacking Hepatitis B Virus polymerase; ENOB-CV-01 for coronavirus treatment; ENOB-CV-11 for coronavirus prophylaxis; ENOB-FL-01 for influenza treatment; ENOB-FL-11 for influenza prophylaxis; and ENOB-DC-11 for off the shelf dendritic cell vaccine for multiple solid tumors.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
253,493 |
| Total Buy Value |
$0 |
$0 |
$0 |
$2,027,944 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
253,493 |
| Total Sell Value |
$0 |
$0 |
$0 |
$2,027,944 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sindlev Rene |
Director |
– • • |
2024-02-20 |
4 |
OE |
$0.53 |
$250,000 |
I/I |
471,699 |
13,605,297 |
|
- |
|
| Abildgaard Ole |
10% Owner |
– – • |
2024-02-13 |
4 |
A |
$0.00 |
$0 |
I/I |
3,436,190 |
7,898,482 |
|
- |
|
| Sindlev Rene |
Director |
– • • |
2024-02-13 |
4 |
A |
$0.00 |
$0 |
I/I |
701,260 |
13,133,598 |
|
- |
|
| Miller Avram |
Director |
– • – |
2023-10-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000,000 |
1,000,000 |
|
- |
|
| Abildgaard Ole |
10% Owner |
– – • |
2023-10-03 |
4 |
A |
$0.00 |
$0 |
I/I |
500,000 |
7,398,482 |
|
- |
|
| Abildgaard Ole |
10% Owner |
– – • |
2023-08-22 |
4 |
A |
$0.00 |
$0 |
I/I |
500,000 |
6,898,482 |
|
- |
|
| Abildgaard Ole |
10% Owner |
– – • |
2023-08-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
417% |
|
| Abildgaard Ole |
10% Owner |
– – • |
2023-08-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,462,292 |
|
417% |
|
| Sindlev Rene |
Director |
– • • |
2023-06-26 |
4 |
A |
$0.53 |
$1,000,001 |
I/I |
1,886,794 |
12,432,338 |
|
- |
|
| Sindlev Rene |
Director |
– • • |
2023-03-17 |
4 |
A |
$1.14 |
$1,000,000 |
I/I |
877,193 |
10,545,544 |
|
- |
|
| Weird Science Llc |
|
– – • |
2022-10-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,216,467 |
1,313,499 |
|
- |
|
| William Anderson Wittekind |
|
– – • |
2022-10-13 |
4 |
A |
$0.00 |
$0 |
I/I |
1,216,467 |
1,313,499 |
|
- |
|
| Sindlev Rene |
Director |
– • • |
2022-06-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(253,493) |
0 |
|
- |
|
| Gumrukcu Serhat |
10% Owner |
– – • |
2022-05-18 |
4 |
S |
$8.00 |
$2,027,944 |
D/D |
(253,493) |
12,273,059 |
|
65% |
|
| Sindlev Rene |
Director |
– • • |
2022-05-18 |
4 |
B |
$8.00 |
$2,027,944 |
I/I |
253,493 |
128,493 |
2.25 |
-65% |
|
| Weird Science Llc |
|
– – • |
2022-04-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,961,363) |
97,032 |
|
- |
|
| Sandler Carl Forest Jr |
Former director see note below |
– – – |
2022-04-15 |
4 |
A |
$0.00 |
$0 |
D/D |
992,273 |
4,449,104 |
|
- |
|
| Sandler Carl Forest Jr |
Former director see note below |
– – – |
2022-04-15 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,969,090) |
3,456,831 |
|
- |
|
| Weird Science Llc |
|
– – • |
2022-04-11 |
4 |
A |
$0.00 |
$0 |
D/D |
97,032 |
5,058,395 |
|
- |
|
| William Anderson Wittekind |
|
– – • |
2022-04-11 |
4 |
A |
$0.00 |
$0 |
I/I |
97,032 |
5,058,395 |
|
- |
|
| Sandler Carl Forest Jr |
Director |
– • • |
2022-03-22 |
4 |
AS |
$9.06 |
$17,459 |
D/D |
(1,927) |
3,187,487 |
|
-70% |
|
| Sandler Carl Forest Jr |
Director |
– • • |
2022-02-23 |
4 |
AS |
$9.00 |
$54 |
D/D |
(6) |
3,189,414 |
|
-73% |
|
| Sandler Carl Forest Jr |
Director |
– • • |
2022-02-18 |
4 |
AS |
$9.03 |
$61,348 |
D/D |
(6,792) |
3,189,420 |
|
-79% |
|
| Sandler Carl Forest Jr |
Director |
– • • |
2021-12-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,500 |
3,196,212 |
|
- |
|
| Puche Luisa |
Chief Financial Officer |
• – – |
2021-12-16 |
4/A |
A |
$0.00 |
$0 |
D/D |
16,266 |
16,266 |
|
- |
|
66 Records found
|
|
Page 1 of 3 |
|
|
0.03 (3.17%) 
